Hardy, J F <br/><br/>
Low-dose aprotinin infusion is not clinically useful to reduce bleeding and transfusion of homologous blood products in high-risk cardiac surgical patients.  [electronic resource] 

 -  Canadian journal of anaesthesia = Journal canadien d'anesthesie  Jul 1993 
 - 625-31 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0832-610X 
<br/><br/><label>Standard No.: </label>10.1007/BF03009699  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aprotinin--administration & dosage<br/>Blood Coagulation Tests<br/>Blood Loss, Surgical--prevention & control<br/>Blood Transfusion<br/>Cardiac Surgical Procedures<br/>Double-Blind Method<br/>Erythrocyte Transfusion<br/>Female<br/>Hemoglobins--analysis<br/>Humans<br/>Infusions, Intravenous<br/>Male<br/>Middle Aged<br/>Placebos<br/>Platelet Count<br/>Platelet Transfusion<br/>Reoperation<br/>Risk Factors